Primary Site >> Colorectal Cancer
Gene >> TGFB2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. PMID: 2538337 Ref: Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line. PMID: 2925796 |
Ref: Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta 1 and beta 2. PMID: 1617643 |
Ref: Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. PMID: 8494782 |
Ref: Characterization of mutated transforming growth factor-beta s which possess unique biological properties. PMID: 7918451 Ref: Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. PMID: 8082724 |
Ref: High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. PMID: 7549813 Ref: Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms. PMID: 7593230 Ref: Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors. PMID: 7743502 Ref: Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. PMID: 9019169 |
Ref: Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta. PMID: 9858065 |
Ref: Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. PMID: 10416598 |
Ref: Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. PMID: 11166150 |
Ref: Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells. PMID: 15276867 Ref: Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. PMID: 15326482 Ref: Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung. PMID: 15466481 |
Ref: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells. PMID: 15538569 |
Ref: Obese state leads to elevated levels of TGF-beta and COX isoforms in platelets of Zucker rats. PMID: 16477387 Ref: Expression of Smad4 and TGF-beta2 in colorectal carcinoma. PMID: 16886611 Ref: Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. PMID: 16969489 |
Ref: Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. PMID: 18084956 Ref: [Anticancer effects of tea polyphenols on colorectal cancer with microsatellite instability in nude mice]. PMID: 19063841 |
Ref: Studies of TGF-beta(1-3) in serosal fluid during abdominal surgery and their effect on in vitro human mesothelial cell proliferation. PMID: 19062040 |
Ref: The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-beta2. PMID: 21619536 Ref: Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2. PMID: 21692070 |
Ref: Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. PMID: 22532293 Ref: Induction of the expression of genes encoding TGF-beta isoforms and their receptors by inositol hexaphosphate in human colon cancer cells. PMID: 23614294 Ref: Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab. PMID: 23634291 |
Ref: Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer. PMID: 27081080 |
Ref: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. PMID: 28341962 Ref: DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer. PMID: 28782576 |
Ref: Retraction Note to: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells. PMID: 29313066 Ref: Hypoxic tumor microenvironment activates GLI2 via HIF-1alpha and TGF-beta2 to promote chemoresistance in colorectal cancer. PMID: 29891662 Ref: The TGFbeta-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs. PMID: 29986714 |